<DOC>
	<DOCNO>NCT01009905</DOCNO>
	<brief_summary>This study conduct United States America ( USA ) . The aim observational study collect data concern treatment outcome safety child adult prescribe Norditropin® . Specific objective include : 1 ) develop model define relationship Norditropin dose change insulin-like growth factor ( IGF-I ) treatment outcome , account independent factor age , gender puberty 2 ) determine relative predictive value peak growth hormone ( GH ) IGF-I level factor treatment clinical outcome .</brief_summary>
	<brief_title>An Observational Study ( Registry ) Assessing Treatment Outcomes Safety Children Adults Who Are Prescribed Norditropin® ( Human Growth Hormone )</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Hypopituitarism</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Informed consent obtain Children adult patient treat Norditropin® appropriate condition prescribe physician Patients treat Norditropin® Patients discontinue treatment Norditropin® Known suspect allergy Norditropin® related product Contraindications somatropin treatment consistent Prescribing Information Norditropin®</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>